Immunoassay Market 2026 Report: AI Integration and Multiplex Testing Become Key Trends
来源: Research and Markets via GlobeNewswire
链接: https://www.globenewswire.com/news-release/2026/02/03/3230949/28124/en/Immunoassay-Research-Report-2026-Market-Strategies-Trends-and-Forecasts-2025-2029-by-Application-Technology-Product-User-and-Country-With-Executive-Guides-Impact-of-Artificial-Inte.html
# Market Overview
According to the latest report from Research and Markets, the immunoassay market is undergoing major transformation, and the workhorse of the diagnostic industry is finding new growth momentum through technological innovation. The pandemic has created new demand for rapid, easily accessible diagnostics, and immunoassay is stepping up. Advances in genetic knowledge are creating new markets for immunoassay, and multiplexing is becoming table stakes.
# Market Drivers
## Pandemic Impact
The COVID-19 pandemic has created new demand for rapid, easily accessible diagnostics, and immunoassay technology has received unprecedented attention and development opportunities in this context. Rapid diagnostics, point-of-care testing, biomarkers, and consumer markets are all areas of expansion.
## Genetic Technology Advances
Advances in genetic knowledge are creating new markets for immunoassay. Changes in genetics are reshaping the industry landscape, and the competition and cooperation between traditional immunoassay and PCR, sequencing technologies are reshaping the market.
## Multiplex Testing Demand
Multiplex testing is becoming industry standard, enabling simultaneous analysis of multiple markers in a single test, greatly improving testing efficiency and diagnostic accuracy.
# Technology Trends
## AI Integration
The report specifically emphasizes the significant impact of artificial intelligence on the immunoassay market. AI technology plays an important role in:
– Result analysis and interpretation
– Quality control optimization
– Instrument operation automation
– Data analysis and interpretation
– Clinical decision support
## Instrument Miniaturization
Smart miniaturized instruments are having serious implications for the industry, meaning smaller instrument size, lower costs, and simplified operations, enabling more laboratories and medical institutions to afford and use advanced immunoassay equipment.
## Multiplex vs POCT
There is a tradeoff analysis between multiplex testing and POCT. Multiplex testing offers higher throughput and more comprehensive information but may require more complex instruments; POCT provides rapid, convenient results but may sacrifice some testing throughput.
# Application Expansion
## Infectious Disease Testing
Infectious disease testing remains the primary application area for immunoassay, and the pandemic has further driven development in this area.
## Tumor Marker Testing
With increasing demand for early cancer diagnosis and treatment monitoring, the tumor marker testing market is growing rapidly.
## Cardiac Disease Diagnosis
Cardiac marker testing has important value in the diagnosis of acute coronary syndromes, heart failure, and other diseases.
## Endocrine Diseases
Hormone testing plays a key role in the diagnosis and treatment monitoring of endocrine diseases.
## Autoimmune Diseases
Autoimmune disease testing demand continues to grow as diagnostic capabilities improve.
# Product Segments
## Instrument Market
The instrument market is undergoing transformation, with miniaturization, automation, and intelligence becoming major trends. Lower instrument costs enable more laboratories to equip advanced immunoassay equipment.
## Reagents and Kits
Reagents and kits are the core of the immunoassay market. With the expansion of testing menus, the kit market is booming. Physician office laboratories are becoming a new frontier.
## Software and Services
With increasing instrument complexity and growing data analysis needs, the importance of software and services continues to rise.
# Rapid Testing and POCT Threat
Rapid testing and POCT are threatening traditional instrument markets but also creating new opportunities. Consumer channels are opening wider, and direct-to-consumer (DTC) testing has huge market potential.
# Industry M&A
The report mentions several important M&A events in the industry, including:
– Quidel acquiring Ortho Clinical Diagnostics
– Beckman Coulter launching DxI 9000 Access Immunoassay Analyzer
– Multiple companies collaborating in the infectious disease rapid testing field
# Company Commentary
As a professional immunoassay raw material supplier, Wuhan Henrysintai is closely monitoring AI integration and multiplex testing technology trends. Our core capabilities highly align with market development directions:
## Chemiluminescence (CLIA) Raw Material Advantages
We provide high-quality chemiluminescence reagent raw materials, including luminescent labels, antibodies, enzymes, and substrates, meeting the needs of high-sensitivity immunoassay. Our high-purity synthesis technology ensures batch consistency and stability of raw materials.
## Multiplex Testing Raw Material Solutions
Targeting the multiplex testing trend, we provide various high-specificity antibodies and antigens, supporting the development of kits that simultaneously detect multiple markers. Our products can ensure no cross-interference between different detection channels in multiplex testing.
## AI-Empowered Quality Control
We are introducing AI technology to optimize raw material production and quality control processes, improving batch consistency and product quality stability through machine learning algorithms.
## POCT Raw Material Support
Targeting the rapid growth of the POCT market, we have developed high-quality antibodies, antigens, and labels suitable for rapid testing, supporting the development of POCT products.
## Domestic Substitution Promoter
We are committed to helping partners reduce dependence on imported raw materials through self-developed high-performance immunoassay raw materials, gaining advantages in global immunoassay market competition. Our product quality meets international standards and has competitive advantages in AI integration and multiplex testing.